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Abstract
Objectives We used data from the Global Burden of Dis-
ease 2015 study (GBD) to calculate the burden of lower
respiratory infections (LRIs) in the 22 countries of the
Eastern Mediterranean Region (EMR) from 1990 to 2015.
Methods We conducted a systematic analysis of mortality
and morbidity data for LRI and its specific etiologic fac-
tors, including pneumococcus, Haemophilus influenzae
type b, Respiratory syncytial virus, and influenza virus. We
used modeling methods to estimate incidence, deaths, and
disability-adjusted life-years (DALYs). We calculated
burden attributable to known risk factors for LRI.
Results In 2015, LRIs were the fourth-leading cause of
DALYs, causing 11,098,243 (95% UI
9,857,095–12,396,566) DALYs and 191,114 (95% UI
170,934–210,705) deaths. The LRI DALY rates were
higher than global estimates in 2015. The highest and
lowest age-standardized rates of DALYs were observed in
Somalia and Lebanon, respectively. Undernutrition in
childhood and ambient particulate matter air pollution in
the elderly were the main risk factors.
Conclusions Our findings call for public health strategies
to reduce the level of risk factors in each age group,
especially vulnerable child and elderly populations.
Keywords Lower respiratory infection  Incidence 
Mortality  DALY  Eastern Mediterranean Region
Introduction
Lower respiratory infections (LRIs) are one of the leading
causes of death and disability-adjusted life-years (DALYs)
worldwide, especially among children under 5 (Kassebaum
et al. 2016; Wang et al. 2016). Since 1990, LRI has been the
closest competitor of cardiovascular diseases as the top
leading cause of DALYs in the Eastern Mediterranean Region
(EMR) and the Arab world (Mokdad et al. 2014, 2016).
Several factors, such as poverty, indoor and outdoor air pol-
lution, malnutrition, smoking, chronic lung diseases, and
delayed and inappropriate case management contribute to the
high burden of LRI (Hadi 2003). Population-based measures
of morbidity and mortality of LRI are scarce. Most of the
available data are limited to children and are based on
modeling approaches. Even fewer data are available for
causative agents of LRI (Kovacs et al. 2015).
Rudan et al. estimated an incidence of 0.22 episodes of
community-acquired pneumonia per child-year in children
under 5 in low- and middle-income countries in 2010
(Rudan et al. 2013) The Child Health Epidemiology Ref-
erence Group (CHERG) estimated 0.26 episodes per child-
year for the world and 0.28 for the World Health Organi-
zation’s (WHO) Eastern Mediterranean Region (EMR).
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These estimates translate to about 20 million cases of
childhood pneumonia each year in the EMR, with
approximately 10% of cases requiring hospitalization
(Rudan et al. 2008). More than 99% of all LRI deaths occur
in low- and middle-income countries. Although about 62%
of children with severe LRI reach hospitals, more than 80%
of all childhood LRI deaths take place outside the hospital
setting (Nair et al. 2013; Tong 2013). Despite high levels of
morbidity and mortality, the decreasing trend in LRI
mortality rates has contributed to increasing life expec-
tancy worldwide (Wang et al. 2016). Improvements in
nutritional status (less malnutrition through attention to
childhood and maternal nutritional status), increased
uptake of vaccines such as immunization against Strepto-
coccus pneumoniae (pneumococcus) and Haemophilus
influenzae type b (Hib) in children and high-risk popula-
tions in EMRs, and improved access to antibiotics and
supportive care have decreased the incidence and fatality of
LRI in many countries (Williams and Shah 2012; Tong
2013).
In this study,we report findings from theGlobal Burden of
Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015)
on LRI in the 22 countries of the EMR between 1990 and
2015.We describe the burden of LRI and a subset of specific
etiologic pathogens, including pneumococcus, Hib, respi-
ratory syncytial virus (RSV), and influenza virus, based on
deaths, years of life lost (YLLs), years lived with disability
(YLDs), and disability-adjusted life-years (DALYs).
Methods
GBD 2015 covers 195 countries, 21 regions, and seven
super-regions from 1990 to 2015 for 315 diseases and
injuries and 79 risk factors. A counterfactual approach was
used for estimating LRI etiologies, one of the method-
ological differences compared to GBD 2010. Detailed
descriptions of the methodological approach for GBD 2015
have been published elsewhere (Forouzanfar et al. 2016;
Kassebaum et al. 2016; Vos et al. 2016; Wang et al. 2016).
The EMR consists of 22 countries with different levels
of gross national income (GNI) per capita. The low-income
countries (LICs) are Afghanistan, Djibouti, Somalia, and
Yemen. The middle-income countries (MICs) are Egypt,
Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Pakistan,
Palestine, Sudan, Syria, and Tunisia. The high-income
countries (HICs) are Bahrain, Kuwait, Oman, Qatar, Saudi
Arabia, and the United Arab Emirates (UAE).
All types of LRI (bronchitis, bronchiolitis, and pneu-
monia) were included in this study. We used the following
International Classification of Diseases (ICD-10) codes (or
their corresponding codes from earlier ICD versions) as
equivalent to LRI: J09–J15.8, J16–J16.9, J20–J21.9, P23-
P23.9, and Z25.1. The ICD-10 codes for etiologic cate-
gories of LRI included J09–J11.89 and Z25.1 for Influenza
virus, J12.1 for RSV, J13, J13.0, J15.3, J15.4, and J15.6 for
pneumococcus, J14 and J14.0 for Hib, and J12, J12.0,
J12.2–J12.9, J15–J15.9, J15.5, J15.7, J15.8, J16–J16.9,
J20–J21.9, and P23-P23.9 for other LRI. We did not
include tuberculosis in this study; it has been classified as a
separate item in GBD.
An analysis of available data on all-cause mortality for
all countries was undertaken (Wang et al. 2016). For
pathogen-specific mortality rates of LRI, we used a coun-
terfactual approach based on the epidemiological concept
of attributable mortality. The change in LRI was estimated
assuming the condition that a specific pathogen was not
present. We adopted different approaches to estimate
bacterial and viral causes based on the available data. For
pneumococcal and Hib LRI, we estimated the causal
fraction from vaccine efficacy trials data. For RSV and
influenza, we relied on observational studies that measured
causal fractions among hospital admissions for LRI (Vos
et al. 2016; Wang et al. 2016). We estimated the causal
fractions among cases by country, age, and sex. To account
for the higher case-fatality rate of bacterial versus viral
LRI, we applied a relative case-fatality differential based
on hospital data that included cases coded to the specific
pneumonia causes. Our mortality estimates were used to
calculate cause-specific YLLs for each age, sex, location,
and calendar year.
To estimate LRI-related morbidity, a systematic review
of studies on epidemiological indicators of LRI was done
as part of the GBD standard methodology. We used 197
sources of data from EMR countries (46 for non-fatal
outcomes and others for cause of death) which contained
data on LRI. A list of all data sources is available on the
Institute for Health Metrics and Evaluation’s website.
(Institute for Health Metrics and Evaluation) A series of
Bayesian meta-regression analyses through DisMod-MR
2.1 were used for disease modeling. Model-based epi-
demiological estimates in combination with disability
weights were used to calculate cause-specific YLDs for
each age, sex, location, and calendar year. DALYs were
calculated through summation of YLLs and YLDs
(Kassebaum et al. 2016; Vos et al. 2016).
We estimated burden of LRI attributable to childhood
malnutrition (underweight, wasting, and stunting), non-
exclusive breastfeeding, zinc deficiency, smoking, sec-
ondhand smoke exposure, household air pollution from
solid fuels, and ambient air pollution as known LRI risk
factors. Details on definitions and measures of age- and
sex-specific relative risks of LRI for each of the risk factors
are available elsewhere (Forouzanfar et al. 2016).
We report 95% uncertainty intervals (UI) for each
estimate—such as rates or numbers of deaths or DALYs.
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We estimated UIs by taking 1000 samples from the pos-
terior distribution of each quantity and using the 25th- and
975th-ordered draws of the uncertainty distribution.
Results
LRI deaths decreased by 30.2% from 273,714 (95% UI
239,890–306,648) in 1990 to 191,114 (95% UI
170,934–210,705) in 2015 in EMR countries. In spite of
the decrease, LRI is still the third-leading cause of death
for all ages in 2015. The death rate per 100,000 was 74.0
(95% UI 64.8–82.9) in 1990 and decreased to 29.5 (95% UI
26.4–32.5) in 2015, a 60.1% reduction. The age-standard-
ized death rate for LRI was 65.4 (95% UI 58.6–73.4) in
1990 and declined by 38.5% to 40.2 (95% UI 36.0–45.2) in
2015. In 2015, 4.8% (95% UI 4.3–5.2) of all deaths and
13.0% (95% UI 11.5–14.7) of under-5 deaths were due to
LRI.
At the regional level, the highest death rates and num-
bers of deaths were among children under 5 years old,
followed by those aged 65 years or older. However, there
was considerable heterogeneity in the age pattern of LRI
deaths between the countries of the EMR. In all high-in-
come countries (Bahrain, Saudi Arabia, Kuwait, Oman,
Qatar, and UAE), and some of the middle-income countries
(Iran, Lebanon, Libya, Morocco, Palestine, Syria, and
Tunisia), the LRI death rates among older age groups were
greater than the mortality rates among children under
5 years. Death rates were 31.5 per 100,000 (95% UI
27.3–35.4) in men compared to 27.4 per 100,000 in women
(95% UI 23.9–31.2) in the region. The LRI death rate was
not different in EMR countries in boys versus girls under 5
(2015).
Figure 1 shows the age-standardized death rates for LRI
by EMR country in 2013. Somalia, Djibouti, and Afgha-
nistan had the highest death rates in the region.
Among the etiologic causes, pneumococcus had the
highest mortality rate (16.6 per 100,000, 95% UI
10.0–22.9), followed by respiratory syncytial virus (1.5 per
100,000, 95% UI 0.9–2.4), Haemophilus influenzae type b
(1.1 per 100,000, 95% UI 0.0–2.3), and influenza virus (0.8
per 100,000, 95% UI 0.5–1.2). Figure 2 demonstrates the
contribution of different etiologic causes to LRI deaths by
age.
The rate of YLLs per 100,000 population decreased by
69.5% from 5579 (95% UI 4,831–6,320) in 1990–1702
(95% UI 1,510–1,902) in 2015. However, LRI was still the
third-leading cause of YLLs in 2015.
e-Table 1 shows age-standardized incidence rates of
LRI in males and females of the EMR countries. The
highest incidence rate was observed in Afghanistan and the
Fig. 1 Age-standardized death
rates of lower respiratory tract
infections per 100,000
population in the countries of
the Eastern Mediterranean
Region, Global Burden of
Disease study, 2015
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lowest in Tunisia for both sexes. In all countries but
Afghanistan, Bahrain, and Djibouti, the incidence rates
were higher among men than women, with the highest
male-to-female ratio in Iran and Libya.
The rate of YLDs per 100,000 decreased from 15.8
(95% UI 10.7–22.9) to 9.7 (95% UI 6.5–13.6) per 100,000
during 1990–2015.
Total DALYs from LRI decreased by 40.6%, from
20,746,747 (95% UI 17,954,899–23,444,142) in 1990 to
11,098,243 (95% UI 9,857,095–12,396,566) in 2015. LRI,
which was the leading cause of DALYs in 1990, was
ranked fourth in 2015, behind ischemic heart disease,
neonatal preterm birth complications, and neonatal
encephalopathy. LRI DALY rates were 5594 (95% UI
4851–6334) and 1712 (95% UI 1520–1912) DALYs per
100,000 population in 1990 and 2015, respectively, a
69.4% reduction. About 4.9% (95% UI 4.3–5.5) of DALYs
in all ages and 12.2% (95% UI 10.8–13.8) of DALYs in
children under 5 were due to LRI in 2015.
Age-standardized DALY rates were 3411 per 100,000
(95% UI 2,993–3,824) in 1990 compared to 1518 per
100,000 (95% UI 1357–1673) in 2015 in the EMR. Global
age-standardized DALY rates for LRI were lower than
those in the EMR: 3310 (95% UI 3033–3551) in 1990, and
1428 (95% UI 1330–1511) in 2013. There was a 56.9%
reduction in age-standardized DALY rates at the global
level, which was similar to the EMR (55.5% reduction)
during 1990–2015. Figure 3 presents trends in age-stan-
dardized and all-ages LRI DALY rates between 1990 and
2015 globally and for the EMR.
Figure 4 shows age-standardized LRI DALY rates in the
EMR countries. The highest rates were seen in Somalia,
Afghanistan, and Djibouti. LRI DALY rates did not differ
significantly between males and females.
Figure 5 shows DALY rates for different etiologies of
LRI in EMR countries in 2015. The largest variation in
country-specific DALYs (highest to lowest ratio) was
observed for Hib (2068.7) compared to 125.5 for pneu-
mococcus, 109.4 for RSV, and 30.6 for influenza. The
DALY rate for Hib was less than one DALY per 100,000 in
UAE and Qatar, compared to 916.7 in Somalia and 458.5 in
Afghanistan (Fig. 5).
Figure 6 shows the LRI DALY rates attributable to
different risk factors in 2015. Childhood undernutrition,
household air pollution from solid fuels, ambient particu-
late matter pollution, suboptimal breastfeeding, second-
hand smoke, no handwashing with soap, and zinc
deficiency were the most important risk factors for LRI in
children under 5. Among those aged 70 years or older,
ambient particulate matter pollution, household air pollu-
tion from solid fuels, smoking, no handwashing with soap,
secondhand smoke, and alcohol use were the main risk
factors.
Discussion
Our study showed a substantial burden of LRI in the EMR.
Despite a decline in the burden of LRI since 1990, LRI
remained the fourth-leading cause of DALYs and third-
leading cause of death in the region in 2015. The all-ages
burden of LRI in the EMR is considerably higher than
global rates, and even the age-standardized burden is
slightly higher. Our findings call for intensified efforts to
control and reduce the burden of LRI in the EMR,
Fig. 2 Number of lower respiratory tract infection deaths by etiologic causes in the Eastern Mediterranean Region, Global Burden of Disease
study, 2015
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especially among low-income countries and low-resource
settings. Moreover, since the current situation of health
status and LRI varies widely between the EMR countries,
suggested interventions to avert LRI deaths and disabilities
should be specified at the national or even subnational level
(Akseer et al. 2015).
The unstable political situation and wars in many of the
EMR countries present a major challenge for controlling
communicable diseases in the region (Haq et al. 2013).
Countries with highest burden of LRI (Somalia, Afgha-
nistan, and Djibouti) have been involved in armed con-
flicts and social unrest in recent decades. Conflict-affected
children experience significant increases in deaths due to
diarrheal diseases, malnutrition, respiratory infections,
and measles (Guha-Sapir and Panhuis 2004). These are
due to different causes such as displacement of popula-
tions, breakdown of health and social services, and
increased risk of disease transmission (Murray et al.
2008). Beyond improving social determinants that affect
LRI, a combination of public health and clinical strategies
is required to control them (World Health Organization
and UNICEF 1986). The ‘‘Protect, Prevent, and Treat’’
framework provides a blueprint for such interventions
(Qazi et al. 2015). The need for an integrated global
action plan led to the launch of the Global Action Plan for
the Prevention and Control of Pneumonia and Diarrhea
Fig. 3 Trends of age-
standardized (AS) and all-age
(AA) DALY rates of lower
respiratory infections in the
Eastern Mediterranean Region
and the world, Global Burden of
Disease study, 1990–2015
Fig. 4 Age-standardized
disability-adjusted life-years
(DALYs) rates of lower
respiratory tract infections per
100,000 population in the
countries of Eastern
Mediterranean Region, Global
Burden of Disease study, 2015
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(GAPPD), which can be used by EMR countries as well
(Qazi et al. 2015).
Immunization is one of the most effective public health
strategies to prevent and reduce the burden of LRI, such as
immunization against pneumococcal infection, Hib, and
Fig. 5 Disability-adjusted life-
years (DALYs) rates for
different etiologies of lower
respiratory tract infections in the
countries of the Eastern
Mediterranean Region, Global
Burden of Disease study, 2015
Fig. 6 Disability-adjusted life-years (DALYs) attributable to risk factors of lower respiratory tract infections, Eastern Mediterranean Region,
Global Burden of Disease study, 2015
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seasonal influenza. Immunization is highly effective at
reducing the burden of ill health from pneumococcal
infection and Hib, but less so for influenza. The effec-
tiveness of influenza vaccination depends on the match
between the antigenic strains included in the vaccine and
the circulating strains in the community, and this can vary
substantially from year to year. EMR countries are at dif-
ferent stages of adopting these vaccines. High-income
EMR countries have introduced pneumococcal conjugate
vaccine (PCV) to their national immunization programs.
Moreover, all low-income countries in the region except
Somalia have introduced PCV thanks to support from Gavi,
the Vaccine Alliance. (Gavi 2017 the Vaccine Alliance)
Somalia has issues with under-coverage of immunization,
even for traditional vaccines such as DTP vaccine (diph-
theria, tetanus, and pertussis). The majority of middle-in-
come countries in the region (Egypt, Iran, Iraq, Jordan,
Lebanon, Syria, and Tunisia), have yet to introduce PCV or
are in the early stages of planning (Moradi-Lakeh and
Esteghamati 2013; Sibak et al. 2015).
All EMR countries have introduced Hib vaccine to their
immunization programs, and coverage of Hib3 in the EMR
has increased from 13% in 2005 to 72% in 2014. However,
coverage of Hib3 varies across EMR countries (World
Health Organization 2017). Hib3 coverage was 75% or less
in five countries in 2014: Somalia, Syria, Iraq, Pakistan,
and Afghanistan (World Health Organization 2017). The
coverage rate in Syria dropped from 80% in 2010 to 43%
due to the ongoing war in the country (World Health
Organization 2017). Iran was the last country in the region
to introduce Hib vaccine in late 2014 and has not yet
published coverage data. Economic sanctions against Iran
had an impact on health policies and slowed down imple-
mentation of immunization programs and policies
(Kheirandish et al. 2015; Massoumi and Koduri 2015).
There are different immunization policies against sea-
sonal influenza virus in EMR countries. Although the
impact of the influenza vaccine on prevention of LRI is not
as clear as that of conjugate vaccines against pneumococcal
infections and Hib, its effectiveness in protecting specific
high-risk groups against severe influenza-associated dis-
ease and death is generally accepted (Voordouw et al.
2003; Nichol et al. 2007). Indeed, the policies for influenza
vaccination are impacted by national capacities, resources,
and epidemiological status (World Health Organization
2012). In the countries that have already established vac-
cination programs, a number of strategies such as public
education and reminders for parents and immunization
providers can increase immunization coverage (Williams
et al. 2011).
Improving diet and nutritional status in the population
groups that are most vulnerable to LRI, such as children
and elderly people, can help prevent infection.
Additionally, enhancing breastfeeding and encouraging
zinc supplementation can reduce the burden of childhood
LRI in the region (Roth et al. 2008, 2010; Shah et al. 2013).
Moreover, based on our data, reducing indoor air pollution
(mainly due to household use of solid fuels) and outdoor air
pollution (especially ambient particulate matter) contribute
to reducing the burden of disease in all age groups (Ren-
zetti et al. 2009; Rehfuess et al. 2009). Unfortunately,
many countries of the region suffer from air pollution:
while Afghanistan, Pakistan, Somalia, Sudan, and Yemen
have considerable issues with household air pollution,
more countries are affected by outdoor air pollution
(Afghanistan, Egypt, Iran, Iraq, Lebanon, Libya, Pakistan,
Saudi Arabia, Syria, and Tunisia) (Cohen et al. 2017;
World Health Organization Eastern Mediterranean Region
2017). Smoking and exposure to secondhand smoke are
other factors that influence LRI (Oberg et al. 2011). Most
of the countries of the region (all except Somalia and
Morocco) have ratified the Framework Convention on
Tobacco Control (FCTC), which provides a baseline for
tobacco control (Framework Convention Alliance Parties
to the WHO 2017). However, the anti-smoking activities
need to be boosted (Usmanova and Mokdad 2013) and
expanded to shisha use, which is very common in the
region (Moradi-Lakeh et al. 2015).
Access to adequate health care and appropriate case
management (rapid diagnosis, access to antibiotics and
supportive care) are important therapeutic interventions for
LRI control (Bhutta et al. 2013). Although in general health
care access has improved in EMR countries, there is still
limited access to high-quality health care due to avail-
ability, accessibility, acceptability, and costs, especially for
those who live in remote areas as well as disadvantaged
groups (Kronfol 2012; Takian et al. 2013). The use of
simple, standardized guidelines for diagnosis and treatment
of LRI reduces complications and deaths. These guidelines
should be made available to all care facilities including
community health facilities and mobile units (Kronfol
2012; Takian et al. 2013). Unfortunately, many EMR
countries have not implemented such evidence-based
guidelines. Although the required expertise and local data
for developing guidelines are not available in the majority
of EMR countries, adaptation of international guidelines
can be used as an alternative method to increase quality of
care (Rashidian 2008). On the other hand, several countries
in the region (such as Libya, Syria, and Yemen, as the most
recent examples) have experienced considerable setbacks
in access to health care because of war, social unrest, and
mass displacement of populations (Dewachi et al. 2014;
Burki 2015). Shortages in the provision of acute care,
inpatient and outpatient clinical services as well as primary
care services, and access to essential medicines are among
the most urgent issues in such unstable conditions.
Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and… S103
123
Moreover, continuity of providing preventive and health
promotion services is difficult during war and instability;
several reports have demonstrated the effect of war on
childhood malnutrition and the inability to maintain a cold
chain for vaccines during the wars in Afghanistan, Iraq,
and Yemen (Assefa et al. 2001; Levy and Sidel 2016; Burki
2016). These are among the well-known LRI risk factors.
Surveillance systems are crucial for planning and
managing LRI and identifying emerging infections (Brei-
man et al. 2013). In 2015, several outbreaks of LRI
occurred in the EMR, for instance influenza A(H1N1)
pdm09 in Libya, Kuwait, and Jordan; avian influenza A
(H5N1) in Egypt; and Middle East respiratory syndrome
coronavirus (MERS-CoV) in Saudi Arabia and Jordan
(WHO Regional Office for the Eastern Mediterranean
2016). However, many EMR countries do not have ade-
quate health information systems to monitor the situation
of LRI. (World Health Organization and UNICEF 2013)
Therefore, it is important to assist countries to set up such
systems to identify and manage outbreaks, and monitor the
trends and risk factors of LRI. It also helps to improve
accuracy of estimates for EMR in the next rounds of the
GBD study.
Our study has some limitations. First, there are not
enough original data for all countries of the region. For
instance, many countries did not have estimates on inci-
dence or etiologic agents of LRI. However, we used
modeling approaches to estimate the burden, even for
countries with limited data. While we did not assess avian
influenza, severe acute respiratory syndrome (SARS), and
MERS-CoV (Beaute´ et al. 2014; Milne-Price et al. 2014) as
separate etiologic agents, all of them were included in total
numbers of incidence, deaths, and DALYs.
Conclusion
LRI is one of the leading causes of morbidity and mortality
in the EMR. Efforts are urgently needed to prevent and
control LRI in the region, especially in the low-income
countries of the region. All countries should consider
adopting vaccines against pneumococcus, if they have not
already, to reduce the burden. To adequately address the
LRI burden, a public health and health care systems
approach is needed. A comprehensive plan that includes
addressing known risk factors such as poor diet, smoking,
and exposure to secondhand smoke; health systems to
improve prevention and treatment of cases; and community
programs to increase awareness and immunization uptake
are needed. A reliable surveillance system is required to
monitor trends of disease burden and evaluate new
interventions.
Unstable economies, political instability, and unrest in
the region are major barriers to improving health.
Therefore, it is important for the international community
to work to improve political stability in the EMR, and to
strengthen support for low-income countries and disad-
vantaged groups, in order to reduce LRI morbidity and
mortality in the region.
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